Free tool
FAERS Monitor: Plan B One-Step
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021998 or its brand name (Plan B One-Step, Levonorgestrel). Reports on generic versions are filed under their own applications.
Reports
42,154
Serious
4,490
11% of reports
Hospitalization
676
Death reported
59
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- menstruation irregular13,709
- vaginal haemorrhage7,830
- nausea4,998
- menstruation delayed4,893
- dysmenorrhoea3,952
- vomiting3,321
- headache2,373
- pelvic pain2,274
- fatigue2,098
- pregnancy after post coital contraception1,973
- drug ineffective1,926
- dizziness1,914
- abdominal pain1,686
- vaginal discharge1,650
- breast tenderness1,648
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 39 |
| 2005 | 39 |
| 2006 | 37 |
| 2007 | 27 |
| 2008 | 22 |
| 2009 | 50 |
| 2010 | 85 |
| 2011 | 6,105 |
| 2012 | 4,981 |
| 2013 | 4,226 |
| 2014 | 4,720 |
| 2015 | 4,169 |
| 2016 | 3,887 |
| 2017 | 2,558 |
| 2018 | 1,718 |
| 2019 | 2,548 |
| 2020 | 2,075 |
| 2021 | 665 |
| 2022 | 1,142 |
| 2023 | 949 |
| 2024 | 939 |
| 2025 | 752 |
| 2026 | 421 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,012,005 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| pregnancy after post coital contraceptionSignal | 1,973 | 3414.8 | 3018.8 | 857,342 |
| menstruation irregularSignal | 13,709 | 521.5 | 510.2 | 3,484,701 |
| menstruation delayedSignal | 4,893 | 409.5 | 394.8 | 1,094,965 |
| dysmenorrhoeaSignal | 3,952 | 211.4 | 203.9 | 581,304 |
| breast tendernessSignal | 1,648 | 139.5 | 132.2 | 176,981 |
| vaginal haemorrhageSignal | 7,830 | 109.6 | 107.1 | 691,878 |
| vaginal dischargeSignal | 1,650 | 97.0 | 92.1 | 131,172 |
| pelvic painSignal | 2,274 | 71.2 | 68.2 | 137,824 |
| abdominal painSignal | 1,686 | 3.6 | 3.5 | 3,231 |
| vomitingSignal | 3,321 | 3.5 | 3.4 | 6,152 |
| nauseaSignal | 4,998 | 3.2 | 3.1 | 7,638 |
| dizziness | 1,914 | 1.9 | 1.8 | 857 |
| headache | 2,373 | 1.9 | 1.8 | 1,024 |
| fatigue | 2,098 | 1.3 | 1.3 | 192 |
| drug ineffective | 1,926 | 0.7 | 0.7 | 207 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.